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Aim: This study aimed to investigate the relationship between total dairy intake and dairy subtypes (high-fat
dairy, low-fat dairy, milk and milk products, cheese and fermented dairy) with incident coronary heart
disease (CHD) and stroke.
Methods: EPIC-NL is a prospective cohort study among 33,625 Dutch men and women. At baseline
(1993–1997), dairy intake was measured with a validated food frequency questionnaire (FFQ). The incidence
of both fatal and non-fatal CHD and stroke was obtained by linkage to the national registers.
Results: During 13 years follow-up, 1648 cases of CHD and 531 cases of stroke were documented. Total dairy
intake was not signiﬁcantly associated with risk of CHD (hazard ratio per standard deviation (SD)
increase=0.99; 95%-CI: 0.94–1.05) or stroke (0.95; 0.85–1.05) adjusted for lifestyle and dietary factors.
None of the dairy subtypes was to CHD, while only fermented dairy tended to be associated (p=0.07)
with a lower risk of stroke (0.92; 0.83–1.01). Hypertension appeared to modify the association of total
and low-fat dairy with CHD (p interactionb0.02). Among participants without hypertension, but not
among hypertensive participants, total (0.92; 0.85–1.02) and low-fat (0.94; 0.87–1.02) dairy tended to be
associated with a lower risk of CHD.
Conclusion: Our results provide no evidence that dairy products are associated with risk of CHD or stroke.
High intakes of total and low-fat dairy may be associated with a lower risk of CHD among participants with-
out hypertension, while fermented dairy could be associated with a reduced risk of stroke.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The intake of dairy products was thought to be associated with an
increased risk of cardiovascular diseases (CVD) due to its relatively
high content of saturated fat. Dietary recommendations target a diet
limited in saturated fat, trans fat and cholesterol and therefore advise
consuming fat-free or low-fat dairy products [1]. Such recommenda-
tions have been based on the positive linear relationship among
dietary saturated fat, LDL cholesterol, and CVD risk [2].
However, a recent dose–response meta-analysis of 17 prospective
studies investigated the relation of total dairy, milk, and low-fat and
high-fat dairy with risk of CVD or all-cause mortality. The studypostdoctoral grant (2008T062)
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Ltd. All rights reserved.indicated that milk intake was modestly inversely associated with
CVD risk [3]. For coronary heart disease (CHD), stroke and all-cause
mortality, no signiﬁcant association with milk intake was observed.
The authors also concluded that a limited number of studies are avail-
able to draw ﬁrm conclusions for speciﬁc subtypes of dairy like low-
or high-fat dairy and cheese, in particular for stroke.
Meanwhile, different kinds of dairy products with varying nutri-
ent compositions may have different effects on CHD or stroke risk.
Minerals, protein and vitamins from dairy products can exert blood
pressure- or cholesterol lowering effects, while saturated fat is associ-
ated with an increased risk of CHD [4]. Indeed, one study showed that
in particular the ratio of high-fat dairy to low-fat dairy products is as-
sociated with an increased risk of CHD [5].
In The Netherlands, large quantities and varieties of dairy products
are consumed, compared with other European countries [6]. There-
fore the Dutch population provides an excellent opportunity to inves-
tigate the relation of dairy consumption and its subtypes in relation to
CHD and stroke. The aim of this study is therefore to investigate the
relationship of dairy intake, including the speciﬁc dairy subtypes
high-fat dairy, low-fat dairy, milk and milk products, cheese and
fermented dairy, with CHD and stroke in a large prospective cohort
in the Netherlands.
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2.1. Study population and design
The EPIC-NL cohort is the Dutch contribution to the European Prospective Investi-
gation into Cancer and Nutrition (EPIC) and consists of the Prospect-EPIC and
MORGEN-EPIC cohorts [7]. The Prospect-EPIC study includes 17,357 women aged
49–70 years living in Utrecht and vicinity who participated in the nationwide Dutch
breast cancer screening program between 1993 and 1997. The MORGEN-EPIC cohort
consists of 22,654 men (n=10,260) and women (n=12,349) aged 21–64 years selected
from random samples of the Dutch population in three different towns. Participants were
recruited in both studies from 1993 to 1997. Right from the start, both Dutch cohorts
collaborated closely to obtain maximal synergy on the design of the questionnaires and
to follow identical protocols in the collection of biological samples. Therefore, both cohorts
used standardized questionnaires and followed identical protocols in the collection of
biological samples. Because of the efﬁciency gain in maintaining the cohort infrastructure
and in conducting scientiﬁc analyses the two cohorts were merged into one EPIC-
Netherlands cohort in 2006 [7]. At baseline, a general and a food-frequency questionnaire
(FFQ) were administered, and a medical examination was performed for blood pressure
measurements, anthropometry, and blood sampling. All participants provided informed
consent before study inclusion. The study complies with the Declaration of Helsinki
and was approved by the institutional board of the University Medical Center Utrecht
(Prospect) and the Medical Ethical Committee of TNO Nutrition and Food Research
(MORGEN).
From the total cohort (n=40,011) subjects who did not give permission for link-
age with vital status registries were excluded (n=2717). Additionally, participants
without information on dietary intake (n=172) or with implausibly high or low
scores for total food intake (outside the range of 800–4200 kcal/d for men and
500–3500 kcal/d for women) (n=448) were excluded. Furthermore, subjects with
known cardiovascular disease (n=1099), cancer (n=1485) or diabetes (n=465) at
baseline were excluded, leaving 33,625 participants for the present analysis.
2.2. Dietary assessment
Daily nutritional intakes were obtained from a self administered FFQ containing
questions on the usual frequency of consumption of 79 main food items during the
year preceding enrollment. This questionnaire allows estimation of the average daily
consumption of 178 foods. A registered dietician checked the FFQ for inconsistencies,
which were resolved by contacting the participant. The validity of the FFQ was
assessed against 12 monthly 24-h recalls over a one-year period among 212 men
and women. Spearman correlations were good for milk and milk products (r=0.69
for men, r=0.77 for women) and moderate for cheese (r=0.56 and r=0.32, respec-
tively) [8,9].
Total dairy included all dairy food products except for butter and ice cream. Milk
and milk products included all kinds of milk, yogurt, coffee creamers, curd, pudding,
porridge, custard, and whipping cream. Cheese included all types of cheese except for
curd. Low-fat dairy is deﬁned as milk and milk products with a fat content b2 g/100 g
(skimmed or semi-skimmed milk products) or cheese with a fat content, b20 g/100 g.
High-fat dairy is deﬁned as milk and milk products with a fat content ≥2 g/100 g
(whole milk products) or cheese products with a fat content ≥20 g/100 g. Fermented
dairy included buttermilk, yogurts, and cheese.
2.3. Outcome assessment
Morbidity follow-up data on coronary heart disease (CHD) events and stroke events
were obtained from theDutch Centre for Health Care Informationwhich holds a standard-
ized computerized register of hospital discharge diagnoses. All diagnoses were coded
according to the International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁca-
tion (ICD-9). Follow-up was complete until the ﬁrst of January 2008. The database was
linked to the cohort on the basis of birth date, gender, postal code and general practitioner
with a validated probabilistic method [10]. Information on vital status was obtained
through linkage with themunicipal registries. Causes of death were collected from Statis-
tics Netherlands. Endpoints for the present analysis were CHD (ICD-9; 410–414, 427.5,
798.1, 798.2, 798.9) and stroke (ICD-9; 430-434, 436), whichever came ﬁrst. These end-
points included both fatal and non-fatal cases of CHD and stroke. In a secondary analysis,
we differentiated to non-fatal CHD obtained from hospital discharge diagnoses and CHD
mortality based on causes of death. Finally, to compare our results with the meta-
analysis [3], we used an endpoint of cardiovascular disease deﬁned as a broad range of
fatal and non-fatal vascular diseases including CHD, stroke, peripheral artery disease, con-
gestive heart failure and pulmonary embolism (ICD-9: 410–414, 427.5, 428, 415.1, 443.9,
430–438, 440–442, 444, 798.1, 798.2, 798.9). In a subsample of our cohort, cases of CHD
and acutemyocardial infarction obtained fromhospital discharge diagnoses were veriﬁed
against hospital records. This showed that 91% of CHD events and 97% of acutemyocardial
infarction could be conﬁrmed [11].
2.4. Other measurements
The general questionnaire contained questions on demographic characteristics,
the presence of chronic diseases, and risk factors for chronic diseases. Smoking was
categorized into current, past, and never smoker. Level of education was categorized
as low (primary education up to those completing advanced elementary education),average (intermediate vocational education and higher general secondary education)
or high (higher vocational education and university). Physical activity was assessed
using a questionnaire validated in an elderly population and categorized according to
the Cambridge Physical Activity Index [12]. Because it was not possible to calculate a
physical activity score for 14% of all participants missing scores were imputed using
single linear regression modeling (SPSS MVA procedure). During the baseline physical
examination screening, systolic and diastolic blood pressure measurements were
performed twice in the supine position on the right arm using a Boso Oscillomat
(Bosch & Son, Jungingen, Germany) (Prospect-EPIC) or on the left arm using a random
zero sphygmomanometer (MORGEN-EPIC), from which the mean was taken. Hyper-
tension was considered present when one or more of the following criteria were
met: systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg,
self-reported antihypertensive medication use, or self-report of physician-diagnosed
hypertension. Height, and weight were measured, and BMI was calculated. All mea-
surements were performed according to standard operating procedures. In a 6.5%
random sample of the baseline cohort, total cholesterol was measured using enzymatic
methods and HDL-cholesterol and LDL-cholesterol were measured using a homoge-
neous assay with enzymatic endpoint. These assays, including the haemolytic, icteric
and lipemic indices (absorbance), were all performed on an autoanalyzer (LX20,
Beckman Coulter, Mijndrecht, The Netherlands).
2.5. Data analysis
Participant characteristics are presented as medians, means with standard devia-
tions or percentages. Intakes of total dairy and dairy subtypes were adjusted for total
energy intake according to the residual method [13]. Total dairy and its subtypes
were evaluated as continuous variables per standard deviation of the mean intake
which is 265 g/d for total dairy, 34 g/d for high-fat dairy, 216 g/d for low-fat dairy,
265 g/d for milk and milk products, 13 g/d for cheese and 123 g/d for fermented
dairy. Cox regression was used to estimate the hazard ratio and 95% conﬁdence inter-
val of the relation between total dairy intake and both fatal and non-fatal events of
CHD or stroke. The analyses were repeated for different types of dairy, i.e. high-fat
dairy, low-fat dairy, milk and milk products, cheese, fermented dairy and the ratio of
high-fat to low-fat dairy. The presence of nonlinear associations of total dairy and its
subtypes was explored by including the quadratic term of these intakes (per SD in-
crease) in the model with the linear term. No evidence for nonlinear associations
was found (with p values for quadratic terms ranging from 0.10 to 0.96).
All analyses were stratiﬁed for cohort. The duration of follow-up was calculated as
the interval between date of study entry and the occurrence of a cardiovascular event,
death, loss to follow-up, or January 1, 2008, whichever came ﬁrst. The estimates were
adjusted for age, sex and total energy intake (model 1). The second model additionally
included smoking, BMI, education and physical activity. Further adjustment was made
for the intake of coffee, ethanol, fruit, vegetables, ﬁsh, meat and bread (model 3).
The interaction between total dairy and possible effect modiﬁers, sex, age, BMI and
hypertension was tested by including interaction terms into the model. In sensitivity
analyses, we excluded cases occurring during the ﬁrst 2 years and those participants
censored in the ﬁrst 2 years. To explore whether observed relations were explained
by blood pressure, calcium or potassium, we adjusted for these variables in model 3.
The proportionality assumption was checked visually by means of log minus log
plots with no deviations detected. In the random sample (n=2050), multivariable
linear regression analysis was performed to assess the association between total
dairy or its subtypes (independent variable) and total cholesterol, HDL- and LDL-
cholesterol (dependent variable). Age, sex, total energy intake, smoking, BMI, educa-
tion, physical activity, intake of coffee, ethanol, fruit, vegetables, ﬁsh, meat and bread
were added as confounder.
Two-sided p-values below 0.05 were considered to be statistically signiﬁcant. All
statistical analyses were conducted SAS 9.2 (SAS Institute, Cary, US).
3. Results
During a mean follow-up of 13 years 1648 incident cases of CHD,
including 211 CHD deaths, and 531 stroke cases, including 128 stroke
deaths, were documented. Table 1 shows the baseline characteristics
of the study population. The median energy-adjusted total dairy in-
take was 392 g/d (quartile 1=221 g/d; quartile 3=575 g/d). Low-
fat dairy (median: 230 g/d) accounted for the largest part of dairy in-
take, compared with high-fat dairy (median: 46 g/d). The median
daily intakes of milk and milk products, fermented dairy and cheese
were 356 g/d, 85 g/d and 16 g/d, respectively. Participants with a
high dairy intake were more active, smoked less often, drank less
alcohol and consumed more fruit and vegetables (data not shown).
Adjusted for age, gender and energy intake, dairy intake was
not associated with risk of CHD (HR per SD: 0.97; 95%-CI: 0.92–
1.02). Adjustment for lifestyle and dietary factors further attenuated
the association (HR: 0.99; 95%-CI: 0.94–1.05). None of the dairy sub-
types was related to CHD risk, although for high-fat dairy we
Table 1
Mean (± SD) baseline characteristics and dietary intakes of 33,625 men and women
from the EPIC-NL cohort.
N 33,625
Follow up (years) 13.1
Gender (% male) 25.5
Age at recruitment (years) 49.0±11.9
BMI (kg/m2) 25.6±4.0
Physically active CPAI (%)a 34.6
Systolic BP (mm Hg) 126.1±18.7
Diastolic BP (mm Hg) 77.8±10.6
Hypertension (%) 36.3
High education (%) 20.6
Current smoker (%) 30.1
Total energy (kcal/d) 2041.0±583.6
Dietary intakes (g/d) b,c
Total dairy 392 (234–574)
High-fat dairy 46 (30–67)
Low-fat dairy 230 (106–385)
Milk and milk products 356 (198–538)
Cheese 16.1 (9.7–25.8)
Fermented dairy 85 (45–176)
Fruit 240 (136–354)
Vegetables 130 (101–167)
Fish 7.6 (3.3–14.9)
Meat 105 (65–139)
Bread 134 (99–176)
Coffee 500 (375–750)
Tea 250 (54–500)
Alcohol 5.1 (0.7–15.8)
a CPAI = Cambridge Physical Activity Index.
b All dietary variables were adjusted for total energy.
c Intake of food groups and beverages is presented as median (interquartile range).
Table 3
Univariable and adjusted hazard ratios (95%-CI) for the association of total dairy intake
and dairy subtypesa with incident (fatal or nonfatal) stroke among 33,625 subjects of
the EPIC-NL study.
Stroke (n=531)
Model 1b Model 2c Model 3d
Total dairy intake 0.90 (0.82–0.99) 0.93 (0.84–1.02) 0.95 (0.85–1.05)
Milk and milk products 0.91 (0.83–0.99) 0.93 (0.85–1.02) 0.95 (0.86–1.05)
Fermented dairy 0.86 (0.78–0.95) 0.90 (0.81–0.98) 0.92 (0.83–1.01)
Cheese 0.94 (0.86–1.02) 0.96 (0.88–1.05) 0.96 (0.88–1.06)
High-fat dairy 0.98 (0.90–1.07) 0.99 (0.91–1.07) 0.99 (0.91–1.09)
Low-fat dairy 0.89 (0.81–0.98) 0.92 (0.83–1.01) 0.94 (0.85–1.03)
Ratio high-fat to low-fat 0.98 (0.93–1.03) 0.98 (0.93–1.04) 0.98 (0.93–1.04)
a All HRs are expressed per SD of the mean in g/d.
b Adjusted for gender, age and total energy intake.
c Adjusted for model 1 and physical activity, smoking, education and BMI.
d Adjusted for model 2 and intake of ethanol, coffee, fruit, vegetables, ﬁsh, meat and
bread.
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0.97; 95%-CI: 0.92–1.02) (Table 2). Specifying these analyses to non-
fatal CHD events and CHD mortality, we observed a borderline signif-
icant (p=0.10) inverse relation with a HR of 0.96 (0.90–1.01) per SD
increase for non-fatal events, while a non-signiﬁcant increased risk
was observed for CHD mortality (HRSD=1.05; 0.92–1.20).
In additional analyses total dairy intake was categorized in quar-
tiles. The association remains similar. After full-adjustment there
was no association with CHD risk (HR 0.91; 0.91–1.06 for the highest
versus lowest quartile).
Associations of dairy intake and risk of stroke were generally stron-
ger than for CHD (Table 3). Total dairy consumption was associated
with a lower risk of stroke adjusted for age, gender and total energy
with a HR of 0.90 (0.82–0.99) per SD increase. Fermented dairy (0.86;
0.78–0.95) and low-fat dairy (0.89; 0.81–0.98) were also associated
with a lower risk of stroke in model 1. However, after full adjustment,Table 2
Univariable and adjusted hazard ratios (95%-CI) for the association of total dairy intake
and dairy subtypesa with incident of (fatal or nonfatal) coronary heart disease among
33,625 subjects of the EPIC-NL study.
CHD (n=1648)
Model 1b Model 2c Model 3d
Total dairy intake 0.97 (0.92–1.02) 1.00 (0.95–1.05) 0.99 (0.94–1.05)
Milk and milk products 0.97 (0.92–1.02) 1.00 (0.95–1.05) 0.99 (0.94–1.05)
Fermented dairy 0.95 (0.91–1.00) 0.99 (0.95–1.05) 1.00 (0.95–1.05)
Cheese 0.96 (0.91–1.01) 0.98 (0.93–1.03) 0.99 (0.94–1.04)
High-fat dairy 0.96 (0.92–1.01) 0.98 (0.93–1.03) 0.97 (0.92–1.02)
Low-fat dairy 0.98 (0.93–1.03) 1.01 (0.96–1.06) 1.01 (0.96–1.06)
Ratio high-fat to
low-fat dairy
1.01 (0.97–1.05) 1.02 (0.98–1.06) 1.02 (0.98–1.06)
a All HRs are expressed per SD of the mean in g/d.
b Adjusted for gender, age and total energy intake.
c Adjusted for model 1 and physical activity, smoking, education and BMI.
d Adjusted for model 2 and intake of ethanol, coffee, fruit, vegetables, ﬁsh, meat and
bread.these associations attenuated to non-signiﬁcant with a HR of 0.95
(0.85–1.05) for total dairy. Only fermented dairy tended to be associat-
ed (p=0.07) with a lower risk of stroke with a HR of 0.92 (0.83–1.01)
per SD increase. Finally, when investigating the relation of milk and
milk products with CVD, we observed a similar non-signiﬁcant associa-
tion as for CHD and stroke separately (HR=1.01; 95%-CI: 0.96–1.05).
We did not observe interactions between total dairy intake and
sex, age and BMI. Only for presence of hypertension, we observed
an interaction (pb0.02) with total dairy. Among participants without
hypertension, total dairy (0.92; 0.85–1.02) tended to be associated
(p=0.07) with a lower risk of CHD, while this was not apparent for
those with hypertension. Similar results were observed for milk and
milk products (0.92; 0.85–1.02) and low-fat dairy (0.94; 0.87–1.02)
among normotensive participants.
Adjusting all associations for blood pressure or excluding cases
occurring in the ﬁrst 2 years did not change our results (data not
shown). The associations of total dairy (HR: 0.94; 0.78–1.13) and
milk and milk products (HR: 0.95; 0.81–1.11) with CHD among
normotensive participants attenuated to non-signiﬁcant when we
adjusted for calcium and potassium. Including calcium and potassium
almost completely explained the association of low-fat dairy (1.00;
0.87–1.15) with CHD among normotensive participants. In the ran-
dom sample dairy intake or its subtypes were not associated with
total cholesterol, HDL- or LDL-cholesterol levels (data not shown).
4. Discussion
In this large cohort of 33,625 Dutch men and women, total dairy
consumption was not associated with risk of CHD or stroke. However,
among participants without hypertension, total dairy, milk and milk
products and low-fat dairy consumption tended to be associated
with a reduced risk of CHD. Fermented dairy tended to be associated
with a reduced risk of stroke.
Strengths of this study include its prospective design with over
10 years of follow-up and its large sample size. However, certain
limitations need to be addressed. Firstly, we relied on self-reported
intakes of dairy using an FFQ. This FFQ used was validated against
12 monthly 24-h recalls in a population of 121 subjects [9]. This
study showed good reproducibility (r=067–0.85) and good relative
validity for milk and milk products (r=0.69 for men, r=0.77 for
women), but lower relative validity for cheese intake (r=0.56 and
r=0.32 respectively). This may have diluted the relation of cheese in-
take with CHD or stroke risk. Since dairy intake was assessed at base-
line only, the effects of participants subsequently changing their
pattern of dairy consumption are uncertain. However, we excluded
participants with prevalent diseases and, in a sensitivity analysis,
cases obtained in the ﬁrst 2 years who are most likely to alter their
dietary habits with similar results. Such reverse causation is therefore
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observed associations could be due to differences in other factors
than dairy consumption. Despite adjustment for a large range of
possible confounders, we cannot exclude unknown or unmeasured
confounding.
The results from this study provided no evidence that total dairy
or milk and milk products are associated with risk of either CHD or
stroke. These ﬁndings are in line with a recent meta-analysis, that
showed no signiﬁcant association between total dairy or milk and
milk products with risk of CHD (1.00; 0.96–1.04) or stroke (0.87;
0.72–1.07) [3]. Recently, the Netherlands Cohort Study could not
detect an association between dairy products and all-cause or CVD
mortality as well [14]. Only milk and milk products were inversely
associated with risk of CVD in the meta-analysis with a HR of 0.94
(95%-CI: 0.89–0.99), an endpoint not primarily included in this
study. However, when investigating the association of milk and milk
products with a broad range of CVD in an additional analysis, we ob-
served a similar non-signiﬁcant association as we did for CHD and
stroke. The previously reported reduced CVD risk for milk and milk
products [3] seems to be mainly driven by effects of dairy consump-
tion on stroke, since the association of milk intake with stroke was
stronger than with CHD. Albeit not signiﬁcant, the association of
total dairy and milk and milk products with stroke in our study was
also stronger than for CHD.
Distinguishing between high-fat and low-fat dairy, we could not
detect signiﬁcant associations with CHD or stroke as well, consistent
with most previous studies [3]. Only the study by Hu et al. observed a
lower risk of CHD with high intakes of low-fat dairy [5]. Surprisingly,
in our study, only high-fat dairy tended to be associated with a lower
risk of CHD events, while it was associated with a non-signiﬁcantly
higher risk of CHD mortality. This suggests a speciﬁc relation of high-
fat dairy with fatal CHD that could perhaps be explained by the high
saturated fat content of these dairy products. A recent meta-analysis
indeed showed similar results for high saturated fat intakes with an in-
creased risk of fatal CHD (RR=1.32), while an RR of 0.99was shown for
total CHD [15,16].
Presence of hypertension appeared to modify the relation of total
dairy, milk and milk products and low-fat dairy with risk of CHD. Only
among participants without hypertension, total dairy, milk and milk
products and low-fat dairy were associated with an approximately 8%
reduced risk of CHD per 200–250 g/d, while no association was ob-
served among participants with hypertension. These associations
could be explained by effects of dairy consumption on blood pressure,
since low-fat dairy intake is associated with reduced blood pressure
(relative risk 0.87; 95%-CI 0.74–0.95) [17]. However, adjusting the asso-
ciations between dairy and CHD for systolic and diastolic blood pressure
did not alter our ﬁndings. Moreover, blood pressure is more strongly
related to stroke than CHD [18]. Therefore, risk factorsmore strongly re-
lated to CHD like blood lipids could better explain our results. However,
adjusting for baseline total and HDL cholesterol in part of cohort did not
affect our results (data not shown). In addition, we could not detect
any signiﬁcant associations of total dairy intake and its subtypes with
blood lipid concentrations. It is therefore more likely that other factors
could be involved to explain these associations. Perhaps, minerals
from dairy products could play a role, since adjusting for potassium
and calcium explained part of the association between dairy and CHD.
However, this would then have to be driven by effects on other risk fac-
tors than blood pressure or blood lipids like inﬂammatory factors [19].
Finally, residual confounding could be involved. The DASH-diet was
reported to be more effective for participants with high sodium intakes
[20]. Possibly, hypertensive participants in our cohort already slightly
reduced their sodium intake, while normotensive participants did not.
Unfortunately, a FFQ is not a valid tool to estimate sodium intake and
we can therefore not address this effect.
We observed a borderline signiﬁcant inverse association between
intake of fermented dairy and risk of stroke. Larsson et al. investigatedassociations between fermented dairy products and risk of stroke
and observed an inverse relation between cheese consumption and
cerebral infarction, but not for other fermented dairy foods like
yogurt or buttermilk [21]. Consistently, Goldbohm et al. observed an
inverse relation of fermented full-fat milk with all-cause mortality
and non-signiﬁcantly with stroke mortality [14]. Altogether, these
studies suggest an inverse relation between fermented dairy products
and risk of stroke. Blood pressure- [22] and cholesterol- [23] lowering
effects of fermented dairy could explain these relations. Speciﬁc
tripeptides originating from milk fermentation, for example, have
been suggested to reduce blood pressure [24], but a recent large ran-
domized trial failed to conﬁrm these results [25]. Another explanation
could be the effect of vitamin K2 that is mainly present in fermented
dairy products. Vitamin K2 has been previously shown to reduce
vascular calciﬁcation and subsequent risk of CHD in two prospective
cohorts [26,27], but the relation between vitamin K2 and risk of stroke
has not been investigated to date. Further research on the association
between fermented dairy products and risk of stroke is therefore
warranted.
In conclusion, our results provide no evidence that dairy products
are associated with risk of CHD or stroke in a generally healthy Dutch
population. Among participants without hypertension, high intakes of
total and low-fat dairy could be associated with a lower risk of CHD,
while fermented dairy may be associated with a reduced risk of
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